DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $489,000 | -10.8% | 13,114 | -38.8% | 0.00% | 0.0% |
| Q1 2021 | $548,000 | -48.8% | 21,439 | -55.8% | 0.00% | -60.0% |
| Q4 2020 | $1,070,000 | +16.3% | 48,554 | -5.1% | 0.01% | +25.0% |
| Q3 2020 | $920,000 | -34.9% | 51,149 | -8.0% | 0.00% | -42.9% |
| Q2 2020 | $1,413,000 | +14.8% | 55,615 | -17.0% | 0.01% | -12.5% |
| Q1 2020 | $1,231,000 | +126.3% | 67,004 | +171.4% | 0.01% | +166.7% |
| Q4 2019 | $544,000 | +216.3% | 24,692 | +106.1% | 0.00% | +200.0% |
| Q3 2019 | $172,000 | -9.0% | 11,980 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $189,000 | +7.4% | 11,980 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $176,000 | – | 11,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |